BSGM (BioSig Technologies, Inc.) Total Debt to Capital

Public company logo of BioSig Technologies (BSGM)

Biosig Technologies (BSGM) is developing heart impulse analysis systems, utilizing external contractors for hardware production, which amplifies the importance of vendor quality control. The monetization model relies on the sale of consumables and software licensing. The current debt-to-equity ratio stands at 0.00, while the price action shown below on GURU.Markets reflects profit stagnation due to low device sales volumes.

BSGM: Biosig Technologies Debt to Capital 07/04/2022 - 09/12/2025
Finished products of BioSig Technologies Inc.

High-margin sales of disposable sensors and the software leverage of Biosig Technologies (BSGM) enable the business to scale without excessive capital expenditures on production. By analyzing changes in the debt-to-equity ratio, an investor assesses the proportion of borrowed funds within the financing structure relative to net assets, which determines the degree of financial independence and the company's ability to service obligations through operating cash flow.

Competitors of Biosig Technologies

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio iridex.com IRIX|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Total Debt to Capital Beyond Air Inc XAIR|PFSA - Debt to Equity|SSKN: Debt to Equity|GCTK (GlucoTrack) - Total Debt to Equity Ratio|NanoVibronix Inc. - All Debt to Shareholders' Equity Ratio|VERO (Venus Concept Inc.) - Total Debt to Capital|Debt to Capital nuwellis.com NUWE|Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Debt to Capital Ratio|Avinger, Inc - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.